January 5, 2024
HJF supported program, ACESO Enrolls First Patient in COVID-19 Adaptive Platform Trial
HJF supported program, ACESO Enrolls First Patient in COVID-19 Adaptive Platform Trial
ACESO and HJF announce the enrollment of the first patient in its adaptive platform trial, Prophylaxis and Treatment of COVID-19 (PROTECT-APT)